‹ Back to News & articles

Video: We asked the Millennium Technology Prize 2020 winners what they are researching today

Professors David Klenerman and Shankar Balasubramanian

Will the humankind get rid of cancer and Alzheimer’s disease soon?

One year after receiving the 2020 Millennium Technology Prize for their groundbreaking Next Generation DNA Sequencing technology, Professor Sir Shankar Balasubramanian and Professor Sir David Klenerman visited Finland again. We asked the Millennium Technology Prize winners, what they are researching right now.

Listen to Professor Sir David Klenerman and Professor Sir Shankar Balasubramanian’s latest news on Alzheimer’s disease and cancer research as well as their explanation of what the study of epigenetics is and how it can be used to prevent and slow down the progress of certain diseases.

Epigenetics is the study of how one’s behaviors and environment can cause changes that affect the way the genes work. Epigenetic changes are reversible and do not change your DNA sequence, but they can change how your body reads a DNA sequence.

The 2022 Millennium Technology Prize will be announced and awarded in Finland
on 25 October 2022.


Partners of the Millennium Technology Prize